2 employees
MentiNova develops an oral medication to help treat symptoms of Parkinson’s disease.
2013
$500K
from 1 investors over 1 rounds
MENTINOVA, INC. raised $500K on January 28, 2013
Investors: Foundation Venture Capital Group, LLC